Latest Copart Inc (CPRT) Headlines Hot Small-Cap Picks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Copart Inc (CPRT) Headlines

Hot Small-Cap Picks Abound; Fund Managers Like Copart, Heico
at The Street - Thu Mar 06, 10:58AM CST
Don't be fooled by their stellar run, small-cap stocks still have plenty of steam. But beware speculative biotech stocks.

Forest Laboratories Submits a New Drug Application for Nebivolol and Valsartan Combination in Hypertension
Business Wire - Thu Feb 27, 7:01AM CST
Forest Laboratories, Inc. (NYSE:FRX) announced that it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for a fixed dose combination (FDC) of nebivolol and valsartan for the treatment of hypertension.

Copart Q2 Earnings Lag Ests, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 9:20AM CST
Copart, Inc. reported earnings per share of 35 cents for second-quarter fiscal 2014, up from 31 cents in the corresponding quarter last year.

Copart Reports Second Quarter Fiscal 2014 Financial Results
Business Wire - Tue Feb 25, 5:45PM CST
Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter ended January 31, 2014.

Copart, Inc. to Webcast Second Quarter Fiscal 2014 Results
Business Wire - Fri Feb 21, 4:05PM CST
Copart, Inc. (NASDAQ:CPRT) announced today that it will release earnings for the second quarter of fiscal 2014 after the close of market on Tuesday, February 25, 2014.

App Annie Releases Annual Index: 2013 Retrospective
PR Newswire - Thu Jan 30, 7:00AM CST
WHAT: App Annie Releases Annual Index: 2013 Retrospective

CarMax Falls: Buying Opportunity?
Andrés Cardenal, The Motley Fool - Motley Fool - Mon Jan 06, 9:34AM CST
CarMax has fallen by more than 12% since reporting earnings numbers below Wall Street analysts' expectations on December 20. But the company has a smart and differentiated business model allowing it to outgrow competitors like AutoNation , ...

Consumer Staples Sector Stock Coverage: Wal-Mart Stores, The Fresh Market, Copart, and Lumber Liquidators Holdings
PR Newswire - Thu Dec 26, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.

Why This Unique Car Dealer Will Continue Outperforming
Andrés Cardenal, The Motley Fool - Motley Fool - Wed Dec 04, 8:00AM CST
CarMax has risen by almost 40% over the last year, and the stock is now looking comparatively expensive when compared to peers like AutoNation , Copart and Penske . On the other hand, higher growth rates and a superior business model deserve...

Upgrade Alert for Copart (CPRT)
Comtex SmarTrend(R) - Mon Dec 02, 7:08AM CST
Copart (NASDAQ:CPRT) was upgraded from Equal Weight to Overweight at Stephens today. The stock closed yesterday at $34.43 on volume of 312,000 shares, below average daily volume of 940,000. Copart (NASDAQ:CPRT) has potential upside of 3.8% based on a current price of $34.43 and analysts' consensus price target of $35.75. The stock should discover initial support at its 200-day moving average (MA) of $33.24 and subsequent support at its 50-day MA of $32.50.

Copart Set to Possibly Pullback After Yesterday's Rally of 4.28%
Comtex SmarTrend(R) - Tue Nov 26, 4:53PM CST
Copart (NASDAQ:CPRT) traded in a range yesterday that spanned from a low of $32.30 to a high of $34.17. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high of $32.97 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Copart Q1 Sales Rise, Net Falls
Eric Volkman, The Motley Fool - Motley Fool - Tue Nov 26, 3:57PM CST
Shares of Copart are accelerating in late afternoon trading following the release of the company's fiscal Q1 2014 results . For the quarter, total revenues were just under $280 million, a notable improvement over the $239 million in the same...

Trade-Ideas: Copart (CPRT) Is Today's "Barbarian At The Gate" Stock
at The Street - Tue Nov 26, 9:23AM CST
Trade-Ideas LLC identified Copart (CPRT) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Copart Earnings & Revs Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 26, 7:00AM CST
Copart reported adjusted earnings per share of 35 cents for fiscal first quarter 2014

Copart reports 9.6% decrease in net income for fiscal Q1 2014 year over year
M2 - Tue Nov 26, 3:33AM CST
Copart Inc (NASDAQ:CPRT), a provider of the full range of re-marketing services to vehicle sellers, on Monday reported a net income of USD41.4m or USD0.32 fully diluted earnings per share (down 11% over last year) for the quarter ended 31 October 2013. This was a decrease of USD4.4m or 9.6% over the net income of USD45.8m or USD0.36 fully diluted earnings per share, last fiscal year.

Copart Reports First Quarter Fiscal 2014 Financial Results
Business Wire - Mon Nov 25, 5:15PM CST
Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter ended October 31, 2013.

Business Services Stock Outlook - Nov 2013 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Thu Nov 21, 8:50AM CST
Business Services Stock Outlook - Nov 2013 - Industry Outlook

Business Services Stock Outlook - Nov 2013 - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Thu Nov 21, 8:50AM CST
Business Services Stock Outlook - Nov 2013 - Zacks Analyst Interviews

Copart, Inc. to Webcast First Quarter Fiscal 2014 Results
Business Wire - Wed Nov 20, 4:14PM CST
Copart, Inc. (NASDAQ:CPRT) announced today that it will release earnings for the first quarter of fiscal 2014 after the close of market on Monday, November 25, 2013.

Copart Inc. (CPRT) Stock Research Links

CPRT Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 3

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 2

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

BlackRock's Strong Performance Lifts Market Spirits

Updated Category News Views 62

BlackRock's Earnings Impact Future Market Trends As investors eagerly glance at the market, recent trends suggest a positive shift, particularly with BlackRock, Inc. reporting remarkable third-quarter earnings. The upbeat results have lifted not only the company’s profile but also the sentiments across various sectors. Market Overview In recent trading sessions, U.S....

Continue Reading
Endo Unveils I Got Somebody Campaign for Peyronie's Disease

Updated Category News Views 648

Endo Launches Awareness Campaign for Peyronie’s Disease Endo, Inc. (OTCQX: NDOI) has recently introduced a compelling initiative titled I Got Somebody. This campaign is designed to encourage men to confront their feelings of embarrassment around Peyronie's disease (PD) and to have open discussions about this condition which affects many. The company aims to empower men...

Continue Reading
Investigation Launched into Aehr Test Systems for Investors' Losses

Updated Category News Views 218

Investigation into Aehr Test Systems, Inc. Focused on Investor Protection The Law Offices of Frank R. Cruz are actively investigating Aehr Test Systems, Inc. (NASDAQ: AEHR) in light of significant concerns raised regarding the company’s adherence to federal securities laws. This investigation comes as a response to alarming financial disclosures made public by the...

Continue Reading
SeaStar Medical Advances adult AKI Treatment with Stanford

Updated Category News Views 69

SeaStar Medical Welcomes Stanford Medicine's Enrollment in AKI Trial SeaStar Medical Holding Corporation (NASDAQ: ICU) is excited to announce that Stanford Medicine will begin actively enrolling subjects in its pivotal trial focused on Adult Acute Kidney Injury (AKI). This collaboration emphasizes the company’s mission to enhance treatment options for patients...

Continue Reading
Exciting Updates on Class A Shares for Investors and Stakeholders

Updated Category News Views 163

Important Distribution Announcement for Class A Shareholders In a recent announcement, Real Estate Split Corp. (TSX: RS) has excitedly shared plans to distribute dividends to Class A shareholders. This distribution not only signifies growth but also represents the company's commitment to providing value to its investors. Key Dates for the Upcoming Distribution For...

Continue Reading